Global Antiparasitic Drugs Market Research Report 2025(Status and Outlook)
Description
Report Overview
The antiparasitic drugs market encompasses pharmaceutical products designed to treat infections caused by parasites, including protozoa, helminths (worms), and ectoparasites. These drugs target a wide range of conditions such as malaria, leishmaniasis, schistosomiasis, and parasitic worm infections, addressing both human and veterinary health needs. The market is driven by factors like increasing prevalence of parasitic diseases in tropical and subtropical regions, growing awareness of neglected tropical diseases (NTDs), and rising demand for livestock and pet healthcare. Key players focus on developing novel therapeutics, including combination therapies and vaccines, to combat drug resistance, a significant challenge in this sector. Geographically, high-burden regions like Africa, Asia, and Latin America dominate demand, while North America and Europe lead in R&D and advanced treatment solutions. Regulatory support for orphan drug designations and government-led eradication programs further bolster market growth. However, limited access to healthcare in low-income areas and high treatment costs remain barriers to expansion. The market is segmented by drug class (anthelmintics, antiprotozoals, etc.), application (human, veterinary), and distribution channels (hospitals, retail pharmacies, online platforms), with increasing emphasis on public-private partnerships to improve drug accessibility.
The global Antiparasitic Drugs market size was estimated at USD 1321.9 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antiparasitic Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antiparasitic Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antiparasitic Drugs market.
Global Antiparasitic Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ipca Laboratories Ltd
Zydus Cadila
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Alkem Laboratories Limited
Market Segmentation (by Type)
Anthelmintics
Antiprotozoals
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antiparasitic Drugs Market
Overview of the regional outlook of the Antiparasitic Drugs Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiparasitic Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antiparasitic Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The antiparasitic drugs market encompasses pharmaceutical products designed to treat infections caused by parasites, including protozoa, helminths (worms), and ectoparasites. These drugs target a wide range of conditions such as malaria, leishmaniasis, schistosomiasis, and parasitic worm infections, addressing both human and veterinary health needs. The market is driven by factors like increasing prevalence of parasitic diseases in tropical and subtropical regions, growing awareness of neglected tropical diseases (NTDs), and rising demand for livestock and pet healthcare. Key players focus on developing novel therapeutics, including combination therapies and vaccines, to combat drug resistance, a significant challenge in this sector. Geographically, high-burden regions like Africa, Asia, and Latin America dominate demand, while North America and Europe lead in R&D and advanced treatment solutions. Regulatory support for orphan drug designations and government-led eradication programs further bolster market growth. However, limited access to healthcare in low-income areas and high treatment costs remain barriers to expansion. The market is segmented by drug class (anthelmintics, antiprotozoals, etc.), application (human, veterinary), and distribution channels (hospitals, retail pharmacies, online platforms), with increasing emphasis on public-private partnerships to improve drug accessibility.
The global Antiparasitic Drugs market size was estimated at USD 1321.9 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antiparasitic Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antiparasitic Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antiparasitic Drugs market.
Global Antiparasitic Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ipca Laboratories Ltd
Zydus Cadila
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Alkem Laboratories Limited
Market Segmentation (by Type)
Anthelmintics
Antiprotozoals
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antiparasitic Drugs Market
Overview of the regional outlook of the Antiparasitic Drugs Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiparasitic Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antiparasitic Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
151 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Antiparasitic Drugs
- 1.2 Key Market Segments
- 1.2.1 Antiparasitic Drugs Segment by Type
- 1.2.2 Antiparasitic Drugs Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Antiparasitic Drugs Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Antiparasitic Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Antiparasitic Drugs Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Antiparasitic Drugs Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Antiparasitic Drugs Product Life Cycle
- 3.3 Global Antiparasitic Drugs Sales by Manufacturers (2020-2025)
- 3.4 Global Antiparasitic Drugs Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Antiparasitic Drugs Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Antiparasitic Drugs Market Competitive Situation and Trends
- 3.8.1 Antiparasitic Drugs Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Antiparasitic Drugs Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Antiparasitic Drugs Industry Chain Analysis
- 4.1 Antiparasitic Drugs Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Antiparasitic Drugs Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Antiparasitic Drugs Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Antiparasitic Drugs Market
- 5.7 ESG Ratings of Leading Companies
- 6 Antiparasitic Drugs Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Antiparasitic Drugs Sales Market Share by Type (2020-2025)
- 6.3 Global Antiparasitic Drugs Market Size Market Share by Type (2020-2025)
- 6.4 Global Antiparasitic Drugs Price by Type (2020-2025)
- 7 Antiparasitic Drugs Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Antiparasitic Drugs Market Sales by Application (2020-2025)
- 7.3 Global Antiparasitic Drugs Market Size (M USD) by Application (2020-2025)
- 7.4 Global Antiparasitic Drugs Sales Growth Rate by Application (2020-2025)
- 8 Antiparasitic Drugs Market Sales by Region
- 8.1 Global Antiparasitic Drugs Sales by Region
- 8.1.1 Global Antiparasitic Drugs Sales by Region
- 8.1.2 Global Antiparasitic Drugs Sales Market Share by Region
- 8.2 Global Antiparasitic Drugs Market Size by Region
- 8.2.1 Global Antiparasitic Drugs Market Size by Region
- 8.2.2 Global Antiparasitic Drugs Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Antiparasitic Drugs Sales by Country
- 8.3.2 North America Antiparasitic Drugs Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Antiparasitic Drugs Sales by Country
- 8.4.2 Europe Antiparasitic Drugs Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Antiparasitic Drugs Sales by Region
- 8.5.2 Asia Pacific Antiparasitic Drugs Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Antiparasitic Drugs Sales by Country
- 8.6.2 South America Antiparasitic Drugs Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Antiparasitic Drugs Sales by Region
- 8.7.2 Middle East and Africa Antiparasitic Drugs Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Antiparasitic Drugs Market Production by Region
- 9.1 Global Production of Antiparasitic Drugs by Region(2020-2025)
- 9.2 Global Antiparasitic Drugs Revenue Market Share by Region (2020-2025)
- 9.3 Global Antiparasitic Drugs Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Antiparasitic Drugs Production
- 9.4.1 North America Antiparasitic Drugs Production Growth Rate (2020-2025)
- 9.4.2 North America Antiparasitic Drugs Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Antiparasitic Drugs Production
- 9.5.1 Europe Antiparasitic Drugs Production Growth Rate (2020-2025)
- 9.5.2 Europe Antiparasitic Drugs Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Antiparasitic Drugs Production (2020-2025)
- 9.6.1 Japan Antiparasitic Drugs Production Growth Rate (2020-2025)
- 9.6.2 Japan Antiparasitic Drugs Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Antiparasitic Drugs Production (2020-2025)
- 9.7.1 China Antiparasitic Drugs Production Growth Rate (2020-2025)
- 9.7.2 China Antiparasitic Drugs Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Ipca Laboratories Ltd
- 10.1.1 Ipca Laboratories Ltd Basic Information
- 10.1.2 Ipca Laboratories Ltd Antiparasitic Drugs Product Overview
- 10.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Product Market Performance
- 10.1.4 Ipca Laboratories Ltd Business Overview
- 10.1.5 Ipca Laboratories Ltd SWOT Analysis
- 10.1.6 Ipca Laboratories Ltd Recent Developments
- 10.2 Zydus Cadila
- 10.2.1 Zydus Cadila Basic Information
- 10.2.2 Zydus Cadila Antiparasitic Drugs Product Overview
- 10.2.3 Zydus Cadila Antiparasitic Drugs Product Market Performance
- 10.2.4 Zydus Cadila Business Overview
- 10.2.5 Zydus Cadila SWOT Analysis
- 10.2.6 Zydus Cadila Recent Developments
- 10.3 Merck
- 10.3.1 Merck Basic Information
- 10.3.2 Merck Antiparasitic Drugs Product Overview
- 10.3.3 Merck Antiparasitic Drugs Product Market Performance
- 10.3.4 Merck Business Overview
- 10.3.5 Merck SWOT Analysis
- 10.3.6 Merck Recent Developments
- 10.4 Pfizer
- 10.4.1 Pfizer Basic Information
- 10.4.2 Pfizer Antiparasitic Drugs Product Overview
- 10.4.3 Pfizer Antiparasitic Drugs Product Market Performance
- 10.4.4 Pfizer Business Overview
- 10.4.5 Pfizer Recent Developments
- 10.5 GlaxoSmithKline Plc.
- 10.5.1 GlaxoSmithKline Plc. Basic Information
- 10.5.2 GlaxoSmithKline Plc. Antiparasitic Drugs Product Overview
- 10.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Product Market Performance
- 10.5.4 GlaxoSmithKline Plc. Business Overview
- 10.5.5 GlaxoSmithKline Plc. Recent Developments
- 10.6 Cipla Ltd
- 10.6.1 Cipla Ltd Basic Information
- 10.6.2 Cipla Ltd Antiparasitic Drugs Product Overview
- 10.6.3 Cipla Ltd Antiparasitic Drugs Product Market Performance
- 10.6.4 Cipla Ltd Business Overview
- 10.6.5 Cipla Ltd Recent Developments
- 10.7 Ranbaxy Laboratories
- 10.7.1 Ranbaxy Laboratories Basic Information
- 10.7.2 Ranbaxy Laboratories Antiparasitic Drugs Product Overview
- 10.7.3 Ranbaxy Laboratories Antiparasitic Drugs Product Market Performance
- 10.7.4 Ranbaxy Laboratories Business Overview
- 10.7.5 Ranbaxy Laboratories Recent Developments
- 10.8 Novartis AG
- 10.8.1 Novartis AG Basic Information
- 10.8.2 Novartis AG Antiparasitic Drugs Product Overview
- 10.8.3 Novartis AG Antiparasitic Drugs Product Market Performance
- 10.8.4 Novartis AG Business Overview
- 10.8.5 Novartis AG Recent Developments
- 10.9 Alvizia Health Care
- 10.9.1 Alvizia Health Care Basic Information
- 10.9.2 Alvizia Health Care Antiparasitic Drugs Product Overview
- 10.9.3 Alvizia Health Care Antiparasitic Drugs Product Market Performance
- 10.9.4 Alvizia Health Care Business Overview
- 10.9.5 Alvizia Health Care Recent Developments
- 10.10 Bayer AG
- 10.10.1 Bayer AG Basic Information
- 10.10.2 Bayer AG Antiparasitic Drugs Product Overview
- 10.10.3 Bayer AG Antiparasitic Drugs Product Market Performance
- 10.10.4 Bayer AG Business Overview
- 10.10.5 Bayer AG Recent Developments
- 10.11 Roche Inc
- 10.11.1 Roche Inc Basic Information
- 10.11.2 Roche Inc Antiparasitic Drugs Product Overview
- 10.11.3 Roche Inc Antiparasitic Drugs Product Market Performance
- 10.11.4 Roche Inc Business Overview
- 10.11.5 Roche Inc Recent Developments
- 10.12 Arbor Pharmaceuticals Inc.
- 10.12.1 Arbor Pharmaceuticals Inc. Basic Information
- 10.12.2 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product Overview
- 10.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product Market Performance
- 10.12.4 Arbor Pharmaceuticals Inc. Business Overview
- 10.12.5 Arbor Pharmaceuticals Inc. Recent Developments
- 10.13 Sanofi
- 10.13.1 Sanofi Basic Information
- 10.13.2 Sanofi Antiparasitic Drugs Product Overview
- 10.13.3 Sanofi Antiparasitic Drugs Product Market Performance
- 10.13.4 Sanofi Business Overview
- 10.13.5 Sanofi Recent Developments
- 10.14 AstraZeneca
- 10.14.1 AstraZeneca Basic Information
- 10.14.2 AstraZeneca Antiparasitic Drugs Product Overview
- 10.14.3 AstraZeneca Antiparasitic Drugs Product Market Performance
- 10.14.4 AstraZeneca Business Overview
- 10.14.5 AstraZeneca Recent Developments
- 10.15 Alkem Laboratories Limited
- 10.15.1 Alkem Laboratories Limited Basic Information
- 10.15.2 Alkem Laboratories Limited Antiparasitic Drugs Product Overview
- 10.15.3 Alkem Laboratories Limited Antiparasitic Drugs Product Market Performance
- 10.15.4 Alkem Laboratories Limited Business Overview
- 10.15.5 Alkem Laboratories Limited Recent Developments
- 11 Antiparasitic Drugs Market Forecast by Region
- 11.1 Global Antiparasitic Drugs Market Size Forecast
- 11.2 Global Antiparasitic Drugs Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Antiparasitic Drugs Market Size Forecast by Country
- 11.2.3 Asia Pacific Antiparasitic Drugs Market Size Forecast by Region
- 11.2.4 South America Antiparasitic Drugs Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Antiparasitic Drugs by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Antiparasitic Drugs Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Antiparasitic Drugs by Type (2026-2033)
- 12.1.2 Global Antiparasitic Drugs Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Antiparasitic Drugs by Type (2026-2033)
- 12.2 Global Antiparasitic Drugs Market Forecast by Application (2026-2033)
- 12.2.1 Global Antiparasitic Drugs Sales (K MT) Forecast by Application
- 12.2.2 Global Antiparasitic Drugs Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
